Dianthus Therapeutics (DNTH) has an average rating of buy and mean price target of $139.36, according to analysts polled by FactSet.
What else is happening in Research?
Research
Barrington Research Initiates CTS With Outperform Rating, $80 Price Target
Barrington Research Initiates CTS With Outperform Rating, $80 Price Target
$CTS
Research
William Blair Downgrades Cooper to Market Perform From Outperform
Cooper (COO) has an average rating of overweight and mean price target of $72.77, according to analysts polled by FactSet.
$COO
Research
BNP Paribas Upgrades Telefónica to Neutral Rating, Raises PT
BNP Paribas on Wednesday upgraded telecommunications company Telefónica (TEF.MC) to neutral from an underperform rating and increased its price target to 3.80 euros from 3.20 euros.
$TEF.MC